Blue Vervain

Proposed mechanism

Blue vervain contains iridoid glycosides, chiefly verbenalin and hastatoside — its most-studied constituents and the usual explanation offered for its traditional use as a calming herb. In rats, an aqueous blue vervain extract shortened the time to fall asleep and increased total sleep time, and that effect was reversed by flumazenil, a drug that blocks the benzodiazepine site on the GABA-A receptor, which points to GABA signaling as the likely pathway. Isolated verbenalin and hastatoside also increased deep (non-REM) sleep in rats, and extracts of the related European vervain (Verbena officinalis) produced calming and anti-seizure effects in mice. All of this is animal data from a small number of studies. No clinical trial has tested blue vervain in people, and no study has tested whether it lowers adrenaline or sympathetic fight-or-flight tone, or whether it helps with hypervigilance or other PTSD symptoms. (The human "verbena" stress and sleep trials sometimes cited here used lemon verbena, Aloysia citriodora, an unrelated plant.) Its use for stress or hypervigilance remains traditional, not clinically proven.

Mechanisms describe how researchers think a compound may act, often from laboratory work — a proposed mechanism is not proof of a clinical effect in people.